earticle

논문검색

Systems metabolic engineering of Escherichia coli for L-valine production

초록

영어

The L-valine producing strain of Escherichia coli was constructed by rational metabolic engineering and stepwise improvement based on transcriptome analysis and in silico gene knock-out simulation. Feedback inhibition of acetohydroxy acid synthase isoenzyme III by L-valine was removed by site-directed mutagenesis and the native promoter containing the transcriptional attenuator leader regions of the ilvGMEDA and ilvBN operon were replaced with the tac promoter. The ilvA, leuA and panB genes were deleted to make more precursors available for L-valine biosynthesis. This engineered Val strain harboring pKKilvBN, which overexpresses the ilvBN genes, produced 1.31 g/liter L-valine. Comparative transcriptome profiling combined with in silico gene knock-out simulation was used for the enhanced production of L-valine. The VAMF strain (Val ΔaceF Δmdh ΔpfkA) harboring pKBRilvBNCED and
pTrc184ygaZHlrp was able to produce 7.55 g/liter L-valine from 20 g/liter glucose, resulting in a high yield of 0.378 g L-valine per g glucose. The approaches described here can be a good example of systematically engineering strains for the enhanced production of amino acids. [This work was supported by the Korean Systems Biology Project of the Ministry of Science and
Technology (M10309020000-03B5002-00000). Further supports by the LG Chem Chair Professorship and KOSEF through the CUPS are appreciated].

저자정보

  • Jin Hwan Park Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Center for Systems and Synthetic Biotechnology, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST)
  • Kwang Ho Lee Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Center for Systems and Synthetic Biotechnology, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST), R & D Center for Bioproducts, CJ Corp., Seoul, Korea
  • Tae Yong Kim Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Center for Systems and Synthetic Biotechnology, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST)
  • Joungmin Lee Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Center for Systems and Synthetic Biotechnology, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST)
  • Sang Yup Lee Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Center for Systems and Synthetic Biotechnology, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST), Department of BioSystems and Bioinformatics Research Center, Korea Advanced Institute of Science and Technology (KAIST)

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.